Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Anthocyanins, a class of flavonoid compounds responsible for the red, purple, and blue colors in many fruits and vegetables (such as berries, red cabbage, and purple sweet potatoes), have been increasingly studied for their potential benefits in managing Metabolic Syndrome (MetS). Metabolic Syndrome is a cluster of conditions—such as increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol/triglyceride levels—that together increase the risk of heart disease, stroke, and type 2 diabetes.

Several clinical and preclinical studies suggest that anthocyanins may exert positive effects on multiple components of MetS. These effects include improving insulin sensitivity, lowering blood pressure, reducing oxidative stress, and modulating lipid profiles. For example, a number of randomized controlled trials have reported that anthocyanin supplementation can lower LDL cholesterol and fasting glucose levels in adults with features of MetS. The proposed mechanisms include enhancement of endothelial function, reduction of inflammation, and modulation of gene expression related to glucose and lipid metabolism.

However, while the evidence is promising, it is not uniformly strong or conclusive. Most studies are relatively short-term, use varying doses and sources of anthocyanins, and sometimes have small sample sizes. Meta-analyses generally report modest effects, emphasizing the need for longer, well-controlled studies to confirm clinical benefits. Despite these limitations, current data support the potential of anthocyanins as adjunctive dietary components for managing MetS, alongside standard lifestyle interventions.

More about anthocyanins
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by anthocyanins

Products containing anthocyanins

Douglas Laboratories Ultra Preventive 50+ -EZ Swallow